Search Result "rs12979860 polymorphism"
Impact of Interleukin 28B and ICAM-1 Genetic Polymorphisms on Response to Direct Antiviral Treatment Among HCV Infected Patients
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1328-1335
Author(s): Amel G. Elsheredy,Abdulrahman H. Almaeen,Amany A. Ghazy,Ghada F. Helaly,Ibrahim Amer,Haneen A. Ghazy,Tamer Haydara
Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 25 Year: 2019 Page: 4832-4851
Author(s): Alicja E. Grzegorzewska
Cytokines Polymorphism and mRNA Expression as Biomarkers in HCV Treatment Response
Journal: Recent Patents on Biomarkers
Volume: 4 Issue: 1 Year: 2014 Page: 11-20
Author(s): Fadia M. Attia,Maha M. Enany,Mai H. Saleh,Heba-t-Allah H. Nashaat,Nahaat M. Soliman
IL28B Polymorphism, Blood Interferon-Alpha Concentration, and Disease Stage of HCV Mono-Infected and HCV-HIV Co-Infected Patients
Journal: Current HIV Research
Volume: 11 Issue: 1 Year: 2013 Page: 50-55
Author(s): Michela E. Burlone,Andrea Cerutti,Rosalba Minisini,Carlo Smirne,Elisa Boccato,Elisa Ceriani,Giovanni Rizzo,Olivia Bargiacchi,Simone Bocchetta,Giuseppa Occhino,Mario Pirisi
Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance
Journal: Current Drug Metabolism
Volume: 19 Issue: 3 Year: 2018 Page: 215-223
Author(s): Manu Asthana,Sushil Kumar Sahu,Amit Kumar,Suchitra Mohanty,Sudipta Chakrabarti,Piyanki Das,Nabanita Roy Chattopadhya,Koustav Chatterjee,Shivaram Prasad Singh,Shanmugam Rajasubramaniam,Tathagata Choudhuri
Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades
Journal: Current HIV Research
Volume: 15 Issue: 6 Year: 2017 Page: 440-447
Author(s): Jucelia Stadinicki dos Santos,Sergio Monteiro de Almeida,Guilherme Silveira Ferreira,Juliano Bordignon,Sylvia Lopes Maia Teixeira,Alberto Cardoso Martins Lima,Sonia Mara Raboni
Determinants of Treatment Outcomes for Hepatitis C Infection and the Path to Personalized Medicine
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 9 Issue: 2 Year: 2011 Page: 123-136
Author(s): Sanaa M. Kamal
HCV-Host Interactions: Interplay Part 2: Host Related Determinants and Intracellular Signaling
Ebook: Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815123432123010005
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5219-5238
Author(s): Paola Dongiovanni, Quentin M. Anstee, Luca Valenti
Impact of Dose Reduction on the Efficacy of Triple Therapy for Patients Infected with Genotype 1b and High Viral Loads
Ebook: Advances in Modern Medicine
Volume: 1 Year: 2017
Author(s): Hiroshi Kohno,Hirotaka Kouno,Toshiki Yamaguchi,Atsushi Yamaguchi,Toshio Kuwai
Doi: 10.2174/9781681080239117010032